BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 74.065 USD 1.88% Market Closed
Market Cap: 14.3B USD

Wall Street
Price Targets

BBIO Price Targets Summary
BridgeBio Pharma Inc

Wall Street analysts forecast BBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBIO is 85.262 USD with a low forecast of 42.632 USD and a high forecast of 115.5 USD.

Lowest
Price Target
42.632 USD
42% Downside
Average
Price Target
85.262 USD
15% Upside
Highest
Price Target
115.5 USD
56% Upside
BridgeBio Pharma Inc Competitors:
Price Targets
AZT
Arcticzymes Technologies ASA
59% Upside
PBYI
Puma Biotechnology Inc
17% Downside
BNTX
BioNTech SE
46% Upside
BVXP
Bioventix PLC
137% Upside
006280
Green Cross Corp
28% Upside
PGEN
Precigen Inc
140% Upside
AGIO
Agios Pharmaceuticals Inc
19% Upside
IPH
Innate Pharma SA
201% Upside

Revenue
Forecast

Revenue Estimate
BridgeBio Pharma Inc

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 3 years is 90%.

N/A
Past Growth
90%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BBIO's stock price target?
Price Target
85.262 USD

According to Wall Street analysts, the average 1-year price target for BBIO is 85.262 USD with a low forecast of 42.632 USD and a high forecast of 115.5 USD.

What is BridgeBio Pharma Inc's Revenue forecast?
Projected CAGR
90%

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 3 years is 90%.

Back to Top